Search by Drug Name or NDC
NDC 24208-0780-55 Neomycin and Polymyxin B Sulfates and Bacitracin Zinc 400; 3.5; 10000 [USP'U]/g; mg/g; [USP'U]/g Details
Neomycin and Polymyxin B Sulfates and Bacitracin Zinc 400; 3.5; 10000 [USP'U]/g; mg/g; [USP'U]/g
Neomycin and Polymyxin B Sulfates and Bacitracin Zinc is a OPHTHALMIC OINTMENT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE.
MedlinePlus Drug Summary
Neomycin, polymyxin, and bacitracin ophthalmic combination is used to treat eye and eyelid infections. Neomycin, polymyxin, and bacitracin are in a class of medications called antibiotics. Neomycin, polymyxin, and bacitracin combination works by stopping the growth of bacteria infecting a surface of the eye.
Related Packages: 24208-0780-55Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Neomycin, Polymyxin, and Bacitracin Ophthalmic
Product Information
| NDC | 24208-0780 |
|---|---|
| Product ID | 24208-780_9c2e68b9-9451-4900-8ca4-23953768cbbe |
| Associated GPIs | 86109903104220 |
| GCN Sequence Number | 048544 |
| GCN Sequence Number Description | neomycin/bacitracin/polymyxinB OINT. (G) 3.5MG-400 OPHTHALMIC |
| HIC3 | Q6W |
| HIC3 Description | OPHTHALMIC ANTIBIOTICS |
| GCN | 14283 |
| HICL Sequence Number | 003363 |
| HICL Sequence Number Description | NEOMYCIN SULFATE/BACITRACIN/POLYMYXIN B |
| Brand/Generic | Generic |
| Proprietary Name | Neomycin and Polymyxin B Sulfates and Bacitracin Zinc |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Neomycin sulfate, Polymyxin B Sulfate and Bacitracin Zinc |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | OINTMENT |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 400; 3.5; 10000 |
| Active Ingredient Units | [USP'U]/g; mg/g; [USP'U]/g |
| Substance Name | BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Labeler Name | Bausch & Lomb Incorporated |
| Pharmaceutical Class | Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA064064 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 24208-0780-55 (24208078055)
| NDC Package Code | 24208-780-55 |
|---|---|
| Billing NDC | 24208078055 |
| Package | 1 TUBE in 1 CARTON (24208-780-55) / 3.5 g in 1 TUBE |
| Marketing Start Date | 1995-10-30 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 9.54357 |
| Pricing Unit | GM |
| Effective Date | 2024-02-21 |
| NDC Description | NEOMYC-BACIT-POLYMIX EYE OINT |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis